142 related articles for article (PubMed ID: 35466460)
21. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
[TBL] [Abstract][Full Text] [Related]
22. Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography.
Viertl D; Bischof Delaloye A; Lanz B; Poitry-Yamate C; Gruetter R; Mlynarik V; Ametamey SM; Ross TL; Lehr HA; André PA; Perillo-Adamer F; Kosinski M; Dupertuis YM; Buchegger F
Mol Imaging Biol; 2011 Apr; 13(2):321-31. PubMed ID: 20556524
[TBL] [Abstract][Full Text] [Related]
23. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
[TBL] [Abstract][Full Text] [Related]
24. 3'-[
Tatum JL; Kalen JD; Jacobs PM; Riffle LA; James A; Thang L; Sanders C; Hollingshead MG; Basuli F; Shi J; Doroshow JH
J Transl Med; 2022 Aug; 20(1):375. PubMed ID: 35982453
[TBL] [Abstract][Full Text] [Related]
25. 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.
Hong IK; Kim SY; Chung JH; Lee SJ; Oh SJ; Lee SJ; Oh J; Ryu JS; Kim TW; Kim DY; Moon DH
Anticancer Res; 2014 Feb; 34(2):759-66. PubMed ID: 24511010
[TBL] [Abstract][Full Text] [Related]
26. Semiautomatic synthesis of 3'-deoxy-3'-[18F]fluorothymidine using three precursors.
Teng B; Wang S; Fu Z; Dang Y; Wu Z; Liu L
Appl Radiat Isot; 2006 Feb; 64(2):187-93. PubMed ID: 16129604
[TBL] [Abstract][Full Text] [Related]
27. Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo.
Grierson JR; Shields AF
Nucl Med Biol; 2000 Feb; 27(2):143-56. PubMed ID: 10773543
[TBL] [Abstract][Full Text] [Related]
28. Purification of [18F]-fluoro-L-thymidine ([18F]-FLT) for positron emission tomography imaging.
Bourgeois M; Mougin-Degraef M; Leost F; Cherel M; Gestin JF; Le Bars D; Barbet J; Faivre-Chauvet A
J Pharm Biomed Anal; 2007 Sep; 45(1):154-157. PubMed ID: 17566690
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
30. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
Troost EG; Bussink J; Slootweg PJ; Peeters WJ; Merkx MA; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2010 May; 51(5):713-9. PubMed ID: 20395329
[TBL] [Abstract][Full Text] [Related]
31. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
Lee HJ; Oh SJ; Lee EJ; Chung JH; Kim Y; Ryu JS; Kim SY; Lee SJ; Moon DH; Kim TW
Cancer Chemother Pharmacol; 2015 May; 75(5):1005-13. PubMed ID: 25776904
[TBL] [Abstract][Full Text] [Related]
33. Glucose-Thymidine Ratio as a Metabolism Index Using
Oh S; Youn H; Paeng JC; Kim YH; Lee CH; Choi H; Kang KW; Chung JK; Cheon GJ
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012530
[TBL] [Abstract][Full Text] [Related]
34. Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.
Rowe JA; Morandi F; Wall JS; Akula M; Kennel SJ; Osborne D; Martin EB; Galyon GD; Long MJ; Stuckey AC; LeBlanc AK
Vet Radiol Ultrasound; 2013; 54(3):299-306. PubMed ID: 23464567
[TBL] [Abstract][Full Text] [Related]
35. Optimization of solid-phase extraction (SPE) in the preparation of [
Yao X; Zha Z; Zhao R; Choi SR; Ploessl K; Liu F; Zhu L; Kung HF
Nucl Med Biol; 2019 Apr; 71():54-64. PubMed ID: 31152974
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
Mena E; Lindenberg ML; Turkbey BI; Shih J; Logan J; Adler S; Wong K; Wilson W; Choyke PL; Kurdziel KA
Clin Nucl Med; 2014 Oct; 39(10):874-81. PubMed ID: 25144214
[TBL] [Abstract][Full Text] [Related]
37. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
[TBL] [Abstract][Full Text] [Related]
38. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
[TBL] [Abstract][Full Text] [Related]
39. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
Tseng JR; Dandekar M; Subbarayan M; Cheng Z; Park JM; Louie S; Gambhir SS
J Nucl Med; 2005 Nov; 46(11):1851-7. PubMed ID: 16269599
[TBL] [Abstract][Full Text] [Related]
40. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
Lu L; Jiang L; Guan H; Gao Y; Lu H
Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
